Showing results (21-30 of 83) with videos related to
Sort By:
Pageof 9
Scientific Reports|March 6, 2021
Novel nanotech antioxidant cocktail prevents medical diagnostic procedures ionizing radiation effectsMiguel Gorenberg, Abed Agbarya, David Groshar, et al.Complementary Medicine Research|January 3, 2023
Acupuncture in the Treatment of Panitumumab Skin Toxicity: A Case ReportTzach Nahumi, Ilana Levy, Elad Schiff, et al.European Journal of Cancer (Oxford, England : 1990)|December 11, 2012
Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II studyGil Bar-Sela, Mira Wollner, Liat Hammer, et al.Anti-Cancer Drugs|August 13, 2021
Anti-androgen for myoepithelial tumor: a potent therapy yet a potential misleaderAdham Hijab, Tarek Taha, Tomer Charas, et al.Harefuah|July 29, 2020
[MANAGING LUNG CANCER PATIENTS' CARE DURING THE COVID-19 PANDEMIC]Abed Agbarya, Rasha Khoury, Nicola J Nasser, et al.Current Oncology (Toronto, Ont.)|January 20, 2022
Is Elevation of Alkaline Phosphatase a Predictive Factor of Response to Alectinib in NSCLC?Walid Shalata, Alexander Yakobson, Rachel Steckbeck, et al.Medicina (Kaunas, Lithuania)|July 30, 2025
The Effect of Extended Dissection of Lymph Nodes (D2plus) with Gastrectomy on the Clinical and Oncological Outcomes in Gastric Cancer Patients, Compared to a Standard Dissection (D2)Sahar Lazari, Muhammad Masalha, Forat Swaid, et al.Springerplus|August 1, 2014
Hormone dependent metastatic salivary gland carcinoma: a case reportAbed Agbarya, Salem Billan, Haitam Nasrallah, et al.Biomedicines|June 2, 2021
Treatment of Rare Mutations in Patients with Lung CancerTarek Taha, Rasha Khoury, Ronen Brenner, et al.Cancers|July 13, 2024
Overcoming Chemoresistance in Cancer: The Promise of CrizotinibSanaa Musa, Noor Amara, Adan Selawi, et al.Pageof 9